Back

Prognostic Value of IL21, CXCL9 and CD1A in Cervical Cancer

2026-01-11 allergy and immunology Title + abstract only
View on medRxiv
Show abstract

BackgroundCervical cancer is one of the most common malignant tumors of the female reproductive system. Existing treatments provide limited benefit for patients with advanced, recurrent or metastatic disease, and reliable prognostic markers are lacking. In this study we integrated multi-omic data from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) database. Protein-coding genes meeting the criteria of an adjusted P value < 0.05 and |log2 fold-change| > 5 were screened; ...

Predicted journal destinations